208 / 1851
Challenges for CAR Therapy
• Limitation: Antigen targets with surface expression are often
not specific
• More specific targets are intracelullar (NYESO-1)
• Heterogenous expression of tumor antigen in solid tumors
• Suppressive tumor microenvironment factors
• Highly TOXIC
• Expensive (personalized) and infrastructure is required